Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Fibronectin 1 (FN1) mRNA is the transcript responsible for the synthesis of fibronectin, a high-molecular-weight glycoprotein essential for the assembly of the extracellular matrix (ECM) [1]. This molecule exists in multiple isoforms generated by alternative splicing, playing pivotal roles in cell adhesion, migration, and tissue morphogenesis [1, 2]. In the context of disease, the dysregulation of FN1 mRNA expression is a primary driver of pathological fibrosis in organs such as the liver, kidneys, and lungs, where excessive fibronectin deposition leads to organ dysfunction [3]. Furthermore, FN1 is a well-recognized marker and driver of the epithelial-mesenchymal transition (EMT) in various cancers, facilitating tumor progression and metastasis [4]. Therapeutic interventions targeting FN1 mRNA, including antisense oligonucleotides (ASOs) and small interfering RNAs (siRNAs), are being explored to selectively downregulate fibronectin production in fibrotic and oncogenic environments [5, 6]. However, because fibronectin is vital for normal physiological processes like wound healing and vascular stability, precise delivery and dosing are critical to avoid adverse systemic effects [7]. Sources: [1] UniProt Consortium. Fibronectin (P02751). [2] Pankov, R., & Yamada, K. M. (2002). Fibronectin at a glance. Journal of Cell Science. [3] Valiente-Alandi, I., et al. (2018). Fibronectin is required for repair and remodeling after myocardial infarction. Circulation. [4] Wang, J. P., et al. (2017). Fibronectin promotes cell growth and migration in colorectal cancer. World Journal of Gastroenterology. [5] Zhou, X., et al. (2015). siRNA-mediated knockdown of fibronectin 1 inhibits the proliferation and invasion of colorectal cancer cells. Oncology Reports. [6] Yazdani, S., et al. (2017). Target gene inhibition by antisense oligonucleotides in fibrosis. Advanced Drug Delivery Reviews. [7] Lenselink, E. A. (2015). The Role of Fibronectin in Normal Wound Healing. International Wound Journal.
RNA interference (RNAi) and RNase H-mediated degradation of target mRNA
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Fibronectin 1 mRNA (FN1 mRNA) (FN1 mRNA).